NBSE

NeuBase Therapeutics, Inc. Common Stock

Delisted

NBSE was delisted on the 10th of May, 2024.

34 hedge funds and large institutions have $1.94M invested in NeuBase Therapeutics, Inc. Common Stock in 2022 Q4 according to their latest regulatory filings, with 3 funds opening new positions, 5 increasing their positions, 9 reducing their positions, and 13 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
34
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
1
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
Puts
Net Calls
Net Calls Change
Name Holding Trade Value Shares
Change
Change in
Stake
1
$519K
2
$238K
3
$190K
4
$180K
5
$179K
6
$121K
7
$96.9K
8
$67K
9
$59.6K
10
$59.2K
11
$54K
12
$44K
13
$31K
14
$19K
15
$14.1K
16
$13.1K
17
$10.4K
18
$7.7K
19
$7.21K
20
$7.21K
21
$5.65K
22
$3.36K
23
$3.05K
24
$3K
25
$3K